Anticoagulation Continuing Pharmacy Education Activities
The University of Connecticut has developed these web-based continuing pharmacy education activities to enhance the practice of pharmacists and assist pharmacists in making sound clinical decisions to affect the outcome of anticoagulation therapy for the patients they serve. There will be a total of 12 hours of CPE credit available. Successful completion of these 12 hours (13 activities) or equivalent training will partially prepare the pharmacist for the Anticoagulation Traineeship.
If desired, “bundle” pricing can be obtained by registering for the activities in groups. It consists of thirteen anticoagulation activities in our online selection. See below for further information.
Registration for All Anticoagulation Online Activities (this excludes the traineeship)
The Traineeship is a one-on-one individualized learning experience. We fill the dates on a first come, first serve basis, once all of the pre-requisites have been met.
Anticoagulation Traineeship at the University of Connecticut Health Center, Farmington, CT
2-day practice-based traineeship continuing education activity for registered pharmacists who are interested in the clinical management of patients on anticoagulant therapy and/or who are looking to expand their practice to involve patient management of outpatient anticoagulation therapy. This one-on-one clinical traineeship will provide you with both the clinical and administrative aspects of a pharmacist-managed outpatient anticoagulation clinic. The activity features ample time to individualize your learning experience. A “Certificate of Completion”, suitable for framing, will be awarded upon successful completion of the traineeship.
“I had a very successful and wonderful learning experience that I will treasure and WILL apply to my practice ASAP”
“ ….this is a great program and I do not have enough good things to say about Dr. Durman and Dr. Bui. They have amalgamated the art of customer service and patient care and have integrated my traineeship into their routine without any issues. ” -lp
Please download a UCHC-Anticoagulation-Traineeship-Brochure-2016-17
1/10/17 + 1/11/17-RESERVED
1/17/17 + 1/18/17
1/24/17 + 1/25/17 RESERVED
2/1/17 + 2/2/17 – RESERVED
2/14/17 + 2/15/17
2/28/17 + 3/1/17
3/14/17 + 3/15/17
3/28/17 + 3/29/17
Anticoagulation CE Activities
The activities below are available separately for $15/hr or as a bundle price of $120 for all 13 activities (12 hours). These are the pre-requisites for the anticoagulation traineeship. Any pharmacist who wishes to increase their knowledge of anticoagulation may take any of the programs below.
Online Anticoagulation Traineeship/Pre-Requisite activities.
- Vitamin K Antagonist Pharmacology, Pharmacotherapy and Pharmacogenomics – 1 hour
- New Oral Anticoagulants: Factor IIa and Xa Inhibitors – 1 hour
- Laboratory Monitoring of Anticoagulation – 1 hour
- Heparin/Low Molecular Weight Heparin and Fondaparinux Pharmacology and Pharmacotherapy – 0.5 hours
- Target Specific Oral Anticoagulants (TSOA’s)– 1.0 hour
- Developing an Anticoagulation Clinic – 1.0 hour
- Pharmacist Reimbursement for Anticoagulation Services – 0.5 hour
- Risk Management in Anticoagulation – 1 hour
- Perioperative Management of Warfarin Interruption – 1 hour
- Hypercoagulable States – 1 hour
- Challenging Topics in Anticoagulation – 1 hour
- Available Strategies to Reverse Anticoagulation Medications-1 hour
- Case Studies in Drug Interactions with Anticoagulation Therapy – 1 hour
To register for these Online Anticoagulation activities click here
CONTINUING EDUCATION CREDIT:
The University of Connecticut, School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.